Fulcrum Therapeutics Inc (FULC)
8.18
+0.33
(+4.20%)
USD |
NASDAQ |
Jun 03, 16:00
8.17
-0.01
(-0.12%)
After-Hours: 20:00
Fulcrum Therapeutics Free Cash Flow: -92.50M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -92.50M |
| December 31, 2023 | -91.47M |
| September 30, 2023 | -88.05M |
| June 30, 2023 | -93.24M |
| March 31, 2023 | -100.95M |
| December 31, 2022 | -99.01M |
| September 30, 2022 | -101.58M |
| June 30, 2022 | -96.35M |
| March 31, 2022 | -86.06M |
| December 31, 2021 | -80.19M |
| September 30, 2021 | -78.11M |
| Date | Value |
|---|---|
| June 30, 2021 | -59.77M |
| March 31, 2021 | -55.71M |
| December 31, 2020 | -55.00M |
| September 30, 2020 | -39.30M |
| June 30, 2020 | -47.94M |
| March 31, 2020 | -45.90M |
| December 31, 2019 | -40.34M |
| September 30, 2019 | -45.60M |
| June 30, 2019 | -37.42M |
| March 31, 2019 | -34.34M |
| December 31, 2018 | -31.54M |
Free Cash Flow Range, Past 5 Years
-101.58M
Minimum
Sep 2022
-37.42M
Maximum
Jun 2019
-71.72M
Average
-79.15M
Median
Free Cash Flow Benchmarks
| Bristol-Myers Squibb Co | 12.51B |
| Moderna Inc | -3.672B |
| Pfizer Inc | 5.106B |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.28M |
| Cash from Investing (Quarterly) | 38.13M |
| Cash from Financing (Quarterly) | 1.651M |
| Free Cash Flow Per Share (Quarterly) | -0.4084 |
| Free Cash Flow Yield | -18.28% |